Fundraising Fox

Mythic Therapeutics

Waltham, US · Founded 2018 · Delaware corporation · 4 known investors

mythictx.com ↗
Biotech

Founders & leadership

BF
Brian FiskeExecutive Officer, Director
GE
George EliadesExecutive Officer, Director
SP
Sandra PooleExecutive Officer
AN
Alex NicholsExecutive Officer, Director, Promoter
BR
Bryan RobertsDirector
PH
Peter HechtDirector

Investors · 4

Hemi Ventures, LlcPalo Alto · $250K – $500Kvia Amy Gu · inferred
Lifeforce CapitalChevy Chase · $500K – $5M
Refactor CapitalreportedBurlingame · $1M – $2M
Venrock AssociatesreportedPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$29.9MraisedDec 2024 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George EliadesExecutive Officer, Director
  • Bryan RobertsDirector
  • Peter HechtDirector
  • Sandra PooleExecutive Officer
  • Brian FiskeExecutive Officer, Director
Offering amount
$30.4M
Amount sold
$29.9M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedAug 2020 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alex NicholsExecutive Officer, Director, Promoter
  • Brian FiskeExecutive Officer, Director, Promoter
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.8MraisedAug 2020 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason HansonDirector
  • Josh KopelmanDirector
  • Bryan RobertsDirector
  • Alex NicholsExecutive Officer, Director, Promoter
  • Brian FiskeExecutive Officer, Director, Promoter
Offering amount
$18.8M
Amount sold
$18.8M
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.